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a  b  s  t  r  a  c  t
MUS81-EME1  is a conserved  structure-selective  endonuclease  with  a preference  for  branched  DNA  sub-
strates in  vitro that  correspond  to intermediates  of  DNA  repair.  Cells  lacking  MUS81  or EME1  show  defects
in  the  repair  of  DNA  interstrand  crosslinks  (ICL)  resulting  in  hypersensitivity  to  agents  such  as  mitomycin
C.  In metazoans,  a proportion  of cellular  MUS81-EME1  binds  the SLX4  scaffold  protein,  which  is itself
instrumental  for  ICL  repair.  It was  previously  reported  that mutations  in  SLX4  that  abolished  interaction
with  MUS81  affected  ICL repair  in  human  cells  but not  in murine  cells.  In this  study  we looked  the other
way  around  by  pinpointing  amino  acid residues  in  MUS81  that  when  mutated  abolish  the interaction
with  SLX4.  These  mutations  fully  rescued  the  mitomycin  C  hypersensitivity  of  MUS81  knockout  murine
cells,  but  they  were  unable  to rescue  the  sensitivity  of two  different  human  cell  lines  defective  in MUS81.
These  data  support  an SLX4-dependent  role for MUS81  in the repair,  but not  the  induction  of ICL-induced
double-strand  breaks.  This  study  sheds  light  on  the  extent  to which  MUS81  function  in ICL  repair  requires
interaction  with  SLX4.
©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
MUS81-EME1 is an evolutionarily conserved structure-selective
endonuclease with a preference in vitro for branched DNA sub-
strates such as 3′ flaps, replication forks and nicked Holliday
junctions (HJs) that correspond to intermediates of DNA repair [1].
Cells lacking MUS81 or EME1 show defects in the repair of DNA
interstrand crosslinks (ICL) resulting in hypersensitivity to agents
such as mitomycin C and platinum compounds [2–5]. In meta-
zoans, a proportion of the total cellular pool of MUS81-EME1 binds
the SLX4 scaffold protein [6]. This scaffold is the central coordina-
tor of a DNA repair toolkit that includes two other endonucleases:
XPF-ERCC1 and SLX1 [7–9], which are also required for ICL repair,
together with SLX4 [7–12].
Although both SLX4 and MUS81-EME1 are highly conserved,
budding yeast Slx4 does not associate with Mus81-Mms4Eme1 [13].
So somewhere in evolution SLX4 and MUS81 developed an ability
to interact with each other. Furthermore the interaction of SLX4
with MUS81-EME1 appears to be restricted to late S and G2 phases
of the cell cycle [14]. Also, mutations in murine SLX4 that disrupt
∗ Corresponding author. Tel.: +44 1382 385490; fax: +44 1382 223778.
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the interaction with MUS81 largely abolishes the resolution of
Holliday junctions that escape dissolution but does not affect ICL
repair [11,12]. In this study, we  mapped domains and residues in
MUS81 required for binding to SLX4 and tested the consequences
for ICL repair.
2. Results and discussion
2.1. Mapping the SLX4 interacting region in MUS81
It was previously established that it is the N-terminus (amino
acids 1–86) of the MUS81 subunit of MUS81-EME1 that interacts
with SLX4 [7]. To narrow down the domain in human MUS81
interacting with SLX4, a series of MUS81 fragments were cloned
into a yeast two-hybrid (Y2H)-compatible vector (Fig. S1), fused to
a GAL4-DNA binding domain (MUS81-BD): amino acids (1–250),
(151–350) and (251–551), as well as full-length MUS81 (FL)
(Fig. 1A). A Y2H screen for interaction with full-length SLX4 fused
to a GAL4-activation domain (SLX4-AD) revealed that the MUS81
fragment (1–250) was  capable of interaction with SLX4 (Fig. 1B). To
further narrow down the SLX4-binding region of MUS81, we sub-
divided this region and found that a MUS81 fragment coding for
amino acids 1–106 is sufficient for interaction with SLX4 (Fig. 1A
and B).
http://dx.doi.org/10.1016/j.dnarep.2014.08.004
1568-7864/© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Fig. 1. Identification of MUS81 mutants that abolish interaction with SLX4. (A) MUS81 fragments used in the yeast two-hybrid assay. (B) Yeast were co-transformed with
the  bait and prey plasmid combinations indicated and plated on the media lacking leucine and tryptophan, with or without histidine (top and middle panels) or onto X-Gal
(bottom panel). Y2H assays were performed with a GAL4 DNA binding domain (BD) fusion of MUS81 and activation domain (AD) fusion of SLX4 to detect interaction between
these  proteins. Cells grown on medium lacking LEU and TRP (to select for bait and prey plasmids) were replica-plated to medium lacking LEU, TRP and HIS to test for
activation of the HIS3 reporter gene or tested for lacZ reporter gene activity. (C) Alignment of the N-terminus of MUS81 from different species. Residues were mutated in
pairs  of two to alanine (black lines). The residues that constitute the Helix-hairpin-Helix (HhH) are underlined in red. M.m., Mus  musculus; H.s., Homo sapiens; X.t., Xenopus
tropicalis;  D.r., Danio rerio; D.m., Drosophila melanogaster; S.p., Saccharomyces pombe; S.c., Saccharomyces cerevisiae. (D) HEK293 cells were transiently transfected with
plasmids expressing FLAG-EMPTY, FLAG-MUS81 wild-type (WT) or FLAG-MUS81 carrying double point mutants as shown in (C). Extracts were subjected to western blotting
to  test expression (upper panel) or immunoprecipitation with anti-FLAG antibodies (lower panel). (E) Immunoprecipitates from HEK293 cells co-transfected with plasmids
expressing FLAG-MUS81 (WT), nuclease dead mutant FLAG-MUS81 D307A (D307A), FLAG-MUS81 loss-of-interaction mutants W24A L25A or L66A Q67A and FLAG-EME1
(EME1) were subjected to a nuclease assay with FITC-labeled 3′ flap substrate for time indicated, and the reaction products resolved by gel electrophoresis. FITC-labeled 3′
flap substrate and the cleaved duplex are shown on the right. Western blot confirming the immunoprecipitation with FLAG M2 beads is shown in the left panel.
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2.2. Reverse yeast two-hybrid assay
Low fidelity mutagenic PCR was used to generate mutations in
MUS81 (1–106) fragment, which was recombined into the Y2H-
compatible vector as a fusion with a kanamycin resistance gene.
Resulting MUS81 (1–106) mutants with stop codons or frameshift
mutations in the MUS81 coding sequence were eliminated by
selection at an optimized kanamycin concentration (Fig. S2). The
reporter strain Mav203 has, in addition to HIS3 and lacZ, a URA3
reporter gene driven by GAL4 sites. URA3 encodes orotidine 5-
phosphate decarboxylase (ODCase) that converts 5-fluoroorotic
acid (5-FOA) to 5-fluorouracil causing cell death when plated
on medium containing 5-FOA and thereby selecting for loss-of-
interaction between bait/prey proteins. To this end, Mav203 yeast
were co-transformed with the MUS81 (1–106)-BD allele library and
SLX4-AD and plated on medium containing 5-FOA. Of the hundreds
of colonies that grew on 5-FOA, around 30 were picked, re-streaked
and taken forward for further analysis. A representative group of
ten such clones is shown in Fig. S3A. Sequencing revealed two
single point mutations at residue Leu25 (L25) and Leu47 (L47),
which were chosen for further analysis based on a high frequency of
occurrence. To confirm loss-of-interaction with SLX4, HEK293 cells
were transiently transfected with full-length FLAG-MUS81 carrying
mutations at residues Leu25 and Leu47 (L25P, L25K, L47P, L47K and
L25A, L47A). Immunoprecipitation using FLAG-M2 agarose beads
revealed loss-of-interaction with SLX4 compared with wild-type
MUS81 (Fig. S3B).
2.3. Alanine scanning of conserved residues in MUS81 (1–106)
fragment
As a complementary approach, we carried out alanine scanning
across conserved residues in the N-terminal (1–106) HhH-bearing
region conserved in a range of MUS81 orthologues [15,16]. Pairs
of conserved residues were mutated to alanine, one pair at a
time (Fig. 1C) in full-length FLAG-tagged MUS81, and HEK293
cells were transiently transfected with these mutants or wild-type
FLAG-MUS81. As shown in Fig. 1D, several MUS81 mutants were
identified in this way that could not interact with endogenous SLX4.
Two of the mutants identified i.e. W24A L25A and L66A Q67A,
did not seem to be defective in EME1 interaction when levels of
MUS81 were taken into account and were chosen for further anal-
ysis. Leu25 was also identified in the reverse yeast two-hybrid assay
(see above).
2.4. Effect of loss-of-SLX4-interaction mutants on MUS81
nuclease activity
Most of the cellular complement of MUS81-EME1 does not
interact with SLX4, and we thought it unlikely that preven-
ting interaction with SLX4 would affect the nuclease activity of
MUS81-EME1. To test this, HEK293 cells were co-transfected with
FLAG-MUS81 wild-type (WT) or MUS81 mutants (W24A L25A and
L66A Q67A) that could not interact with SLX4 - and FLAG-EME1.
As control a nuclease dead mutant FLAG-MUS81 D307A (D307A)
was used. Anti-FLAG immunoprecipitates from cells expressing
wild-type MUS81 cleaved the 3′ flap substrate efficiently, but not
from cells expressing the nuclease dead D307A mutant (Fig. S4). As
shown in Fig. 1E, 3′ flap nuclease activity in FLAG immunoprecip-
itates in the context of the MUS81 mutants W24A L25A and L66A
Q67A that did not interact with SLX4 was indistinguishable from
wild-type MUS81.
2.5. Impact of loss-of-SLX4-interaction MUS81 mutants on ICL
repair in mouse cells
We next checked the ability of MUS81 mutants to rescue MMC
hypersensitivity of Mus81−/− MEFs. To this end Mus81−/− MEFs [5]
were infected with retroviruses for stable expression of wild-type
mouse MUS81 (wt-MUS81) or full-length mouse MUS81 carry-
ing the mutations W24A L25A (MUS81 24/25AA) or L66A Q67A
(MUS81 66/67AA). Wild-type and Mus81−/− MEFs were infected
with empty viruses to serve as controls. MUS81 expression in the
complemented Mus81−/− MEFs was  assessed by immunoblotting
of whole cell extracts (Fig. 2A, top panel). While wild-type MUS81
and EME1 were detected in SLX4 immunoprecipitates, the MUS81
loss-of-SLX4-interaction mutants i.e. MUS81 24/25AA and MUS81
66/67AA were not (Fig. 2A, middle panel). Similar results were
obtained when endogenous EME1 was precipitated from cells com-
plemented with the MUS81 mutants (Fig. 2A, bottom panel). SLX4
was detected in EME1 immunoprecipitates from cells expressing
wild-type MUS81, but not MUS81 24/25AA and MUS81 66/67AA
mutants. The complemented Mus81−/− MEFs were used in a clono-
genic survival assay to test sensitivity to MMC.  Mus81−/− MEFs are
hypersensitive to MMC  compared to wild-type MEFs. This sensi-
tivity was  rescued by ectopic expression of wild-type MUS81, and
the MUS81 24/25AA and MUS81 66/67AA mutants were indistin-
guishable from wild-type (Fig. 2B). These data suggest that the role
of MUS81 in ICL repair is independent of its interaction with SLX4
at least in murine cells.
2.6. MUS81 mutants that cannot interact with SLX4 show
defective ICL repair in human HCT116 cells
We tested the ability of the MUS81 24/25AA and MUS81
66/67AA mutants to rescue the ICL hypersensitivity of human
HCT116 colon cancer cells in which the MUS81 gene had been
disrupted [4]. To this end wild-type MUS81 or MUS81 24/25AA
and 66/67AA mutants were expressed in MUS81−/− HCT116
cells. Wild-type and MUS81−/− HCT116 cells transduced with
empty vectors were used as controls. As in MEFs, the MUS81
loss-of-interaction mutants failed to interact with SLX4 in co-
immunoprecipitation experiments (Fig. 2C). Surprisingly, the
24/25AA and 66/67AA mutants were incapable of rescuing MMC
sensitivity in MUS81−/− HCT116 cells (Fig. 2D) in contrast to
Mus81−/− MEFs where MUS81 interaction with SLX4 was  dispens-
able for ICL repair.
2.7. MUS81 mutants that cannot interact with SLX4 show
defective ICL repair in HEK293 cells
To exclude the possibility that the discrepancies observed were
unique to a particular cell type, we wished to test at least one
more human cell line. To this end, two  separate MUS81 specific
siRNAs (#9, #10) were used to deplete MUS81 from HEK293 cells
and a scrambled siRNA (CON) was  used as control. HEK293 cells
were also transfected with plasmids that allowed stable expres-
sion of FLAG–MUS81 or FLAG–MUS81 24/25AA, under the control
of a tetracycline–inducible promoter. These plasmids encoded
MUS81 with conservative mutations that rendered it refractory
to siRNAs #9 and #10. Endogenous MUS81 was knocked down
using siRNA oligos and expression of FLAG-MUS81 (wild-type
or mutant) was induced by tetracycline. HEK293 cells with a
stable expression of a FLAG-empty tag, also under control of a
tetracycline-inducible promoter, were used as a negative con-
trol. The knockdown of endogenous MUS81 and simultaneous
expression of FLAG-tagged MUS81 (wild type or mutant) was con-
firmed using western blotting (Fig. 3A). These cells were then
subjected to clonogenic survival assays. Depletion of MUS81 using
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Fig. 2. MUS81 mutations that cannot interact with SLX4 cause ICL repair defects in human cells but not mouse cells. (A) Mus81−/− MEFs were infected with retroviruses
expressing wild-type MUS81, MUS81 24/25AA or MUS81 66/67AA. Wild-type MEFs (WT) and Mus81−/− MEFs infected with empty virus were used as controls. Extracts
were  subjected to western blotting to test expression (upper panel) or immunoprecipitation with anti-SLX4 (middle panel) and anti-EME1 antibodies (lower panel). (B)
Clonogenic survival analysis of Mus81−/− MEFs stably expressing MUS81, MUS81 24/25AA or MUS81 66/67AA, exposed to MMC.  For each genotype, cell viability of untreated
cells  was defined as 100%. Mus81−/− MEFs infected with empty virus were used as controls. Data are represented as mean ± SEM, n = 3. (C) MUS81−/− HCT116 cells were
infected with retroviruses expressing MUS81, MUS81 24/25AA or MUS81 66/67AA. Wild-type cells (WT) and MUS81−/− HCT116 cells infected with empty virus were used as
controls. Extracts were subjected to western blotting to test expression (upper panel) or immunoprecipitation with anti-MUS81 and anti-SLX4 antibodies (lower panel). (D)
Clonogenic survival analysis of MUS81−/− HCT116 cells stably expressing MUS81, MUS81 24/25AA or MUS81 66/67AA, exposed to MMC. For each genotype, cell viability of
untreated cells was defined as 100%. Wild-type HCT116 and MUS81−/− HCT116 cells infected with empty virus were used as controls. Data are represented as mean ± SEM,
n  = 3.
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Fig. 3. Interaction of MUS81-EME1 with SLX4 is required for repair of ICL-induced DSBs in human cells. (A) HEK293 cells were transfected for stable expression of FLAG-empty
or  siRNA protected FLAG-MUS81 or FLAG-MUS81 24/25AA under a tetracycline inducible promoter. These cells were then transfected with either scrambled (CON) or MUS81
specific siRNA oligos (#9, #10), following which expression of FLAG-tagged MUS81 (wild-type or mutant) was induced. MUS81 expression was blotted using anti-MUS81
antibodies. GAPDH expression served as control. (B) HEK293 cells stably expressing FLAG-only vector were transfected with either scrambled (CON) or MUS81 specific
siRNA  (MUS81 #9). Alternatively, HEK293 cells stably expressing wild type FLAG-MUS81 (MUS81 WT)  or FLAG-MUS81 24/25AA (MUS81 24/25AA) were knocked down for
endogenous MUS81 expression using MUS81 specific siRNA (MUS81 #9). Clonogenic survival analysis of said HEK293 cells was performed following exposure to MMC.  For
each  sample, cell viability of untreated cells was defined as 100%. Data are represented as mean ± SEM, n = 3. (C) Same as in (B) except cells were treated with MUS81 specific
siRNA  #10 (MUS81 #10). For each sample, cell viability of untreated cells was defined as 100%. Data are represented as mean ± SEM, n = 3. (D) Wild-type, MUS81−/− or MUS81
(wild-type or mutant) complemented MUS81−/− HCT116 cells were treated with MMC  (20 ng/ml) for 16 h and then allowed to recover for the times indicated. The proportion
of  cells in each population with more than five H2AX foci at each time point (H2AX positive) was determined by immunofluorescence.
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either siRNA #9 or #10 caused HEK293 cells to be hypersensi-
tive to MMC,  which could be rescued by wild-type MUS81 in
each case, but not by MUS81 24/25AA mutant (Figs. 3B and
C).
2.8. SLX4 interaction with MUS81 is required for repair of DSBs
induced by MMC  in human cells
MUS81 has been implicated in generation of ICL-induced DSBs
[17]. However, as shown in Fig. 3D, we found that MUS81 is not
required for DSB induction in HCT116 cells, which is consistent
with a previous study in Mus81−/− MEFs that showed that ICL-
induced DSBs could occur even in the absence of MUS81 [3]. The
same study also showed that H2AX foci, a widely used marker
for DSBs, persisted for longer in MEFs lacking MUS81 [3]. Thus,
we next wanted to test if MUS81−/− HCT116 cells complemented
with MUS81 loss-of-interaction mutants were similarly defective
in repair of ICL-induced DSBs.
To this end, the disappearance of H2AX foci following a
pulse of MMC  treatment was analyzed in wild-type HCT116,
MUS81−/− HCT116 or MUS81−/− HCT116 cells complemented with
MUS81 (wild-type or mutant). We  observed an elevated number
of MUS81−/− HCT116 cells that were positive for H2AX foci prior
to MMC  treatment as compared to wild-type HCT116 cells, which
was consistent with a previous study of Mus81−/− MEFs [3]. Fol-
lowing MMC  treatment, the proportion of cells positive for H2AX
foci peaked at ∼80% at 24 h in all cell lines tested. Subsequently,
the number of both wild-type HCT116 cells and MUS81−/− HCT116
cells + MUS81 declined to basal levels within 48 h of drug treatment.
However, for MUS81−/− HCT116 cells and MUS81−/− HCT116 cells
complemented with MUS81 mutants that could not interact with
SLX4, the percentage of cells with H2AX foci remained constant at
∼70% for the duration of the experiment. This observation suggests
that in human cells, MUS81-EME1 is required for ICL-induced DSB
repair and this role of MUS81-EME1 is dependent on its interaction
with SLX4.
3. Discussion
At present the basis for the clear difference between human
and murine cells is unclear, but this is not the first evidence of
a disparity between MUS81 function in mice and humans. For
example, studies in MUS81−/− HCT116 cells show that response
to camptothecin (CPT) is dependent on MUS81 whereas, a sep-
arate study showed that Mus81−/− MEFs were resistant to CPT
treatment [3,18]. Further evidence in favor of a functional dis-
parity in ICL repair comes from studies in mutant mice models
for FANC genes. While, cells isolated from these mice are ICL-
sensitive, most mice do not present developmental defects, anemia
and cancer predisposition that are commonly described in FANC
patients [19]. Hence, while mouse models are important tools to
study the mechanistic background of FA, it is important to keep in
mind that there are differences in DNA repair between mice and
humans.
MUS81 has been implicated in ICL-induced DSB formation as
well as during homologous recombination in the latter stages
of crosslink repair [3,17]. Here we found that DSBs induced by
MMC  treatment were not dependent on MUS81, an observa-
tion made previously for SLX4 [6,8]. However, MUS81 mutations
that do not interact with SLX4 cause delayed repair of the DSBs
as judged by H2AX foci. This is consistent with a role for
SLX4-bound MUS81-EME1 in processing repair intermediates at
late stages of ICL repair, perhaps during homologous recombina-
tion.
4. Experimental procedures
4.1. Nuclease assays
Oligonucletotides were purchased from VBC Biotech. The
sequences of the oligonucleotides used to prepare the 3′ flap DNA
substrate are given below:
Oligo 1: 5′-AGCTACCATGCCTGCACGAATTAAGCAATTCGTAATCAT
GGTCATAGCT
Oligo 4: 5′-AATTCGTGCAGGCATGGTAGCT
Oligo 6: 5′-AGCTATGACCATGATTACGAATTGCTTGGAATCCTGACGA
ACTGTAG
Oligo 1 was  labeled with fluorescein isothiocyanate (FITC) at its
5′ end. The 3′ flap substrate was prepared as previously described
in [20]. After immunoprecipitation, FLAG M2 beads were washed in
cell lysis buffer followed by a final wash in nuclease buffer (20 mM
Tris-HCl [pH 7.5], 50 mM NaCl, 10 mM MgCl2, 0.1 mg/ml BSA) and
assay was performed as described in [8]. Reaction products were
analyzed by native PAGE (10% polyacrylamide) in TAE buffer. Gels
were exposed to FLA5000IR, 473 nm,  600 V and viewed using AIDA
image software.
4.2. Clonogenic survival analysis
MEFs or HCT116 cells were seeded in triplicates in 10 cm dishes
and were allowed to attach before treatment. MMC  was added
to cells for 24 h before medium was  replaced with fresh growth
medium. HEK293 cells were seeded in 10 cm dishes at 25% con-
fluence and allowed to adhere overnight. Cells were transfected
with the relevant siRNA for 48 h and cells were split and seeded
in 10 cm dishes (3500 cells/dish). Cells were allowed to adhere for
a minimum of 8 h before MMC  treatment for 24 h. After 10 days
cells were washed, fixed and stained with Giemsa. The number of
colonies with >50 cells were counted. Results were normalized to
plating efficiency.
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